GAIN THERAPEUTICS, INC (GANX) Operating income 2020–2025
GAIN THERAPEUTICS, INC (GANX) annual operating income history from SEC filings — each fiscal year as reported.
-$18.7MFY2025 · since FY2020: -$3.5M → -$18.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$18.7M | +8.1% |
| FY2024 | -$20.4M | +8.5% |
| FY2023 | -$22.3M | -25.2% |
| FY2022 | -$17.8M | -28.6% |
| FY2021 | -$13.8M | -297.4% |
| FY2020 | -$3.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice